1. 1851 Safety analysis, correlation with response and previous treatments of the association of everolimus (EVE) and exemestane (EXE) in 181 metastatic breast cancer patients (MBC). (September 2015) Authors: Moscetti, L.; Vici, P.; Sperduti, I.; Fabbri, M.A.; Natoli, C.; Mancini, M.L.; Sini, V.; D'Onofrio, L.; Pizzuti, L.; Vaccaro, A.; Magnolfi, E.; Magri, V.; Trenta, P.; Ramponi, S.; Roma, C.; Ruggeri, E.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1950 Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. (September 2015) Authors: Gamucci, T.; Mentuccia, L.; Vici, P.; Iezzi, L.; Sperduti, I.; Astone, A.; Marchetti, P.; Pizzuti, L.; Michelotti, A.; Sini, V.; Cassano, A.; Ciancola, F.; Quadrini, S.; Moscetti, L.; Landucci, E.; Sergi, D.; Magnolfi, E.; Natoli, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer: A case control study. Issue 1 (January 2015) Authors: Vizza, E.; Corrado, G.; Mancini, E.; Vici, P.; Sergi, D.; Baiocco, E.; Patrizi, L.; Saltari, M.; Pomati, G.; Cutillo, G. Journal: European journal of surgical oncology Issue: Volume 41:Issue 1(2015:Jan.) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (December 2019) Authors: Cazzaniga, M.E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferraù, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A.R.; Garrone, O.; Gebbia, V. Journal: Breast Issue: Volume 48(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0766 Response of local disease at magnetic resonance after salvage radiotherapy for prostate cancer. (May 2022) Authors: Bottero, M.; Faiella, A.; Giannarelli, D.; Farneti, A.; Bertini, L.; Landoni, V.; Vici, P.; Sanguineti, G. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience. (October 2016) Authors: Moscetti, L.; Vici, P.; Gamucci, T.; Natoli, C.; Cortesi, E.; Marchetti, P.; Santini, D.; Giuliani, R.; Sperduti, I.; Mauri, M.; Pizzuti, L.; Mancini, M.L.; Fabbri, M.A.; Magri, V.; Iezzi, L.; Sini, V.; D'Onofrio, L.; Mentuccia, L.; Vaccaro, A.; Ramponi, S. Journal: Breast Issue: Volume 29(2016) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗